|
Market Cap (4-Jul) $2,416,092 (1,016th) |
Close (30-Jun) $0.016 |
Volume (30-Jun) 5,525,026 |
Shortsold (24-Dec) 11,970 (0.01%) (590th) |
|
52w High $0.082 |
52w Low $0.011 |
P/E - |
EPS -0.05 |
IBX released this announcement to the ASX on 10 February 2021, 13:35. The announcement is not marked as price sensitive, and is 1 page(s) in length and 129.34kb in size.
You can view all announcements from IBX and see how they appear on a price chart on the announcements page.
At the date of this announcement, IBX was 0.006% short sold according to ASIC data. It was ranked the 608th most shorted stock on the ASX. It is now ranked as the 590th most shorted stock on the ASX with 0.006% of total shares short sold as of the latest reported data (24 December 2024).
| Other Recent Announcements from IBX | |
|---|---|
| Expanded collaboration with Siemens Healthineers to US | 28 June 2023, 8:49 |
| Imagion to complete the MagSense HER2 Phase 1 Study | 21 June 2023, 8:27 |
| Imagion Announces New CEO | 19 June 2023, 8:31 |
| Issue of unlisted performance options under EIP | 10 February 2021, 13:35 |
| Appendix 3G | 10 February 2021, 13:34 |
| Appendix 2A - Fully Paid Ordinary Shares | 2 February 2021, 13:39 |
| Cleansing Notice under Section 708A | 2 February 2021, 13:37 |
You must be logged in to post a reply.
Imagion Biosystems 